Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-005732
Filing Date
2021-05-05
Accepted
2021-05-05 11:30:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29336
2 filename2.txt TEXT-EXTRACT 4340
  Complete submission text file 0000000000-21-005732.txt   45362
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filed for) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)